Filing Details
- Accession Number:
- 0001385508-18-000086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-04 16:47:33
- Reporting Period:
- 2018-10-02
- Accepted Time:
- 2018-10-04 16:47:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385508 | Opiant Pharmaceuticals Inc. | OPNT | Metal Mining (1000) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1656633 | Roger Crystal | C/O Opiant Pharmaceuticals, Inc. 201 Santa Monica Blvd, Suite 500 Santa Monica CA 90401 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-02 | 29,297 | $7.25 | 37,772 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-10-02 | 10,144 | $17.51 | 27,628 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-10-03 | 4,300 | $19.23 | 23,328 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-10-04 | 4,006 | $18.43 | 19,322 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option | Disposition | 2018-10-02 | 50,000 | $0.00 | 29,297 | $7.25 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
450,000 | 2015-10-27 | 2025-10-26 | No | 4 | M | Direct |
Footnotes
- The option was exercised pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $19.00 to $19.75. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Pursuant to the Stock Option Agreement, the number of shares issued on a cashless basis is determined by the following formula: Number of shares = (number of options times (prior day closing stock price less exercise price)) divided by the prior day closing stock price.